Sudarshan Pharma Industries Management Change

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY

Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.

Key figure

Net profit ₹8.1 Cr · +92.9% YoY

Board Meeting DateAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries Board Meeting Date

Sudarshan Pharma's board meets 29 October 2026 to consider Q2 results and a fund-raising proposal. Trading window remains closed until 48 hours after results.

SME to Main Board MigrationAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sudarshan Pharma Industries SME to Main Board Migration

Sudarshan Pharma's shares will list on NSE's main board from October 27, 2026, migrating from BSE SME. Trading begins under symbol SUDARSHAN, marking a platform upgrade.

Other Announcement

Sudarshan Pharma Industries Other Announcement

Sudarshan Pharma Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Management ChangeNaksh Precious Metals Ltd VAL

Naksh Precious Metals Management Change

Naksh Precious Metals accepted the resignation of Vadulekar and Associates as statutory auditors and appointed K A R M & Co. effective 9 November 2026. The appointment fills the casual vacancy until the ensuing AGM.

Execution

Upto the ensuing Annual General Meeting

Management ChangePCBL Chemical Ltd PCBL

PCBL Chemical Management Change

PCBL Chemical appointed Rituraj Singh Kalra as Executive Director and Chief - International Markets (Rubber Blacks) effective 9 November 2026. He is designated Senior Management Personnel, based in Belgium.

Management ChangeThermax Ltd THERMAX

Thermax Management Change

Thermax announced that Harsh Mariwala ceased as Non-Executive Lead Independent Director on completing his second five-year term. The filing is a senior board change with no monetary impact.

Management ChangeRaymond Lifestyle Ltd RAYMONDLSL

Raymond Lifestyle Management Change

Raymond Lifestyle appointed Mr. Birajeev Singh as Head – Supply Chain, a Senior Management Personnel, effective November 9, 2026. No monetary value is involved in this senior management appointment.

Management ChangeGeneral Insurance Corporation of India GICRE

General Insurance Corporation of India Management Change

GIC Re renewed Suresh Sindhi's appointment as Appointed Actuary (Life) and Key Managerial Personnel from November 9, 2026. The term is one year.

Management ChangeSI Capital & Financial Services Ltd SI

SI Capital & Financial Services Management Change

S.I. Capital & Financial Services disclosed the resignation of CFO and KMP Ms Jayasree V, effective close of business on 11 November 2026. The filing gives the reason and cessation date, with no appointment named.